David Shofler, DPM, MSHS
Director of Assessment and Assistant Professor
College of Podiatric Medicine
Phone: 909-706-3898 | Fax: 909-706-3500
Website: www.westernu.edu
Join year: 2011
Dr. David Shofler grew up in the San Fernando Valley and was an undergraduate student at the University of California, Berkeley before attending podiatric medical school in Cleveland, Ohio. He then completed a three-year comprehensive surgical residency at Cedars-Sinai Medical Center in Los Angeles, CA.
Master of Science in Health Science | Western University of Health Sciences, Pomona, CA, August 2013
Doctor of Podiatric Medicine | Ohio College of Podiatric Medicine, Cleveland, OH, May 2007
Bachelor of Arts, Mathematics | University of California, Berkeley, Berkeley, CA, May 2002
Podiatric Medicine and Surgery Residency | Cedars-Sinai Medical Center, Los Angeles, CA
Completed residency training at a three-year, intensive podiatric sirgical residency. Obligations included attending surgical cases, running an on-campus clinic and performing in-hospital consultations.
Board Qualified: Foot Surgery | American Board of Podiatric Surgery
Board Qualified: Reconstructive Rearfoot and Ankle Surgery | American Board of Podiatric Surgery
Assistant Professor of Podiatric Medicine, Surgery, and Biomechanis, Western University of Health Sciences College of Podiatric Medicine, Pomona, CA | July 2011-present
Clinical Instructor / Faculty Scholar, Western Univeristy of Health Sciences, Pomona, CA | July 2010-June 2011
Research Assistant, Learner Research Institute - Cleveland Foundation | Fall 2004-Spring 2005
Dr. Shofler treats all aspects of podiatric care. His areas of interest include the diabetic foot, limb salvage, wound care, and preventive diabetic surgery. He is currently involved in several research projects, ranging from improving the outcomes of diabetic patients to improving the quality of podiatric residencies.
Grant Awards
Company: Valeant Pharmaceuticals
Study Title: Efficacy and Safety of Efinaconazole 10% Solution in the Treatment if Onychomycosis in Diabetic Patients
Award: $206,520.00
PI: David Shofler, DPM
Clinical Trials Indentifier: NCT03168841
Company: Amgen Inc.
Study Title: Investigating the Use of Prilia (Denosumab) in the Treatment of Acute Charcot Neurothropathy
Award: $84,464.03
PI: David Shofler, DPM
Clinical Trials Indentifier: NCT03174366
Dean's List 2003 | Ohio College of Podiatric Medicine
Dean's List 2004 | Ohio College of Podiatric Medicine
Having grown up in Southern California, Dr. Shofler enjoys spending his time running, biking, and camping in the area. He also enjoys spending time at home with his family.